Table 1.

 Sequences of short interfering RNAs (siRNAs)

siRNA	Sequence	Comment
Bcl1	5′-CAGGACCUCGCCGCUGCAGACC-3′	Starting position: 1659
	3′-CGGUCCUGGAGCGGCGACGUCUGG-5′
Bcl3	5′-GCCUUUGUGGAACUGUACGGCC-3′	Starting position: 2047
	3′-UACGGAAACACCUUGACAUGCCGG-5′
Bcl5	5′-CAGGACCUCGCCGCUGCAGAC-3′	Starting position: 1659
	3′-CGGUCCUGGAGCGGCGACGUCUG-5′
Bcl8	5′-GCCUUUGUGGAACUGUACGGC-3′	Starting position: 2047
	3′-UACGGAAACACCUUGACAUGCCG-5′
Bcl11	5′-UGUGGAUGACUGAGUACCUGA-3′	Starting position: 1982
	3′-GGACACCUACUGACUCAUGGACU-5′
Control1	5′-GAUGAGGAUCGUUUCGCAUGA-3′	Eukaryotic kanamycin resistance protein
	3′-UCCUACUCCUAGCAAAGCGUACU-5′
Control2	5′-CCACAUGAAGCAGCACGACUU-3′	EGFP expression vector
	3′-CUGGUGUACUUCGUCGUGCUGAA-5′
Control3	5′-ACGGCUAGCUGUGAAAGGUCC-3′	3′ UTR of hepatitis C virus
	3′-UCUGCCGAUCGACACUUUCCAGG-5′

Starting position indicates position of the first nt of the siRNA sense strand in the bcl-2 mRNA (accession No M13994). Specificity of the sequences was verified by a BLAST search against human and murine databases to minimise unspecific or off target effects.